Comparison of high-risk histopathological features in eyes with primary or secondary enucleation for retinoblastoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Comparison of high-risk histopathological features in eyes with primary or secondary enucleation for retinoblastoma

Published:2015-04-14 Issue:10 Volume:99 Page:1366-1371
ISSN:0007-1161
Container-title:British Journal of Ophthalmology
language:en
Short-container-title:Br J Ophthalmol

Author:

Brennan Rachel C,Qaddoumi Ibrahim,Billups Catherine A,Free Tammy L,Haik Barrett G,Rodriguez-Galindo Carlos,Wilson Matthew W

Publisher

BMJ

Subject

Cellular and Molecular Neuroscience,Sensory Systems,Ophthalmology

Reference22 articles.

1. Results of combined chemotherapy and radiotherapy for advanced intraocular retinoblastoma;Kingston;Arch Ophthalmol,1996

2. Combined chemoreduction and adjuvant treatment for intraocular retinoblastoma;Shields;Ophthalmology,1997

3. Superselective ophthalmic artery chemotherapy as primary treatment for retinoblastoma (chemosurgery);Abramson;Ophthalmology,2010

4. Chemoreduction for unilateral retinoblastoma;Shields;Arch Ophthalmol,2002

5. Chemotherapy for retinoblastoma;Chan;Ophthalmol Clin North Am,2005

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Retinoblastoma and Simulating Lesions;Ocular Pathology;2025

2. Retinoblastoma treatment in a Brazilian population. Presentation and long‐term results;Cancer Medicine;2024-01-19

3. Correlating somatic copy number alteration in aqueous humour cfDNA with chemotherapy history, eye salvage and pathological features in retinoblastoma;British Journal of Ophthalmology;2023-03-17

4. A comparison of high risk pathological features between primary and secondary enucleation for retinoblastoma;European Journal of Ophthalmology;2023-02-09

5. The survival analysis and feasibility study of Pars Plana Vitrectomy (PPV) in the treatment of retinoblastoma;Journal of Cancer Research and Clinical Oncology;2022-11-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3